Bank of New York Mellon’s Minerva Neurosciences NERV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,463
Closed -$16K 4664
2022
Q1
$16K Hold
2,463
﹤0.01% 4623
2021
Q4
$16K Hold
2,463
﹤0.01% 4596
2021
Q3
$34K Sell
2,463
-1,382
-36% -$19.1K ﹤0.01% 4473
2021
Q2
$71K Sell
3,845
-11,199
-74% -$207K ﹤0.01% 4268
2021
Q1
$352K Sell
15,044
-231
-2% -$5.41K ﹤0.01% 3845
2020
Q4
$286K Buy
15,275
+1,330
+10% +$24.9K ﹤0.01% 3846
2020
Q3
$355K Sell
13,945
-99
-0.7% -$2.52K ﹤0.01% 3647
2020
Q2
$406K Buy
14,044
+1,664
+13% +$48.1K ﹤0.01% 3576
2020
Q1
$597K Sell
12,380
-191
-2% -$9.21K ﹤0.01% 3259
2019
Q4
$715K Sell
12,571
-2,871
-19% -$163K ﹤0.01% 3397
2019
Q3
$957K Sell
15,442
-484
-3% -$30K ﹤0.01% 3197
2019
Q2
$717K Sell
15,926
-988
-6% -$44.5K ﹤0.01% 3415
2019
Q1
$1.06M Buy
16,914
+211
+1% +$13.3K ﹤0.01% 3132
2018
Q4
$900K Buy
16,703
+848
+5% +$45.7K ﹤0.01% 3165
2018
Q3
$1.59M Buy
15,855
+2,882
+22% +$289K ﹤0.01% 2985
2018
Q2
$857K Sell
12,973
-85
-0.7% -$5.62K ﹤0.01% 3333
2018
Q1
$652K Sell
13,058
-836
-6% -$41.7K ﹤0.01% 3440
2017
Q4
$672K Sell
13,894
-1,250
-8% -$60.5K ﹤0.01% 3454
2017
Q3
$921K Buy
15,144
+3,778
+33% +$230K ﹤0.01% 3268
2017
Q2
$805K Buy
11,366
+1,341
+13% +$95K ﹤0.01% 3374
2017
Q1
$649K Buy
10,025
+161
+2% +$10.4K ﹤0.01% 3448
2016
Q4
$927K Buy
9,864
+2,469
+33% +$232K ﹤0.01% 3300
2016
Q3
$835K Buy
7,395
+1,004
+16% +$113K ﹤0.01% 3267
2016
Q2
$523K Buy
+6,391
New +$523K ﹤0.01% 3517